Esophageal Cancer, Mantle Cell Lymphoma And Diabetic Nephropathy Pipeline Market Review To 2015: Radiant Insights

RadiantInsights.com includes new market research report on “Esophageal Cancer, Mantle Cell Lymphoma And Diabetic Nephropathy Pipeline Market Review To 2015″ to its huge collection of research reports.

Esophageal Cancer – Pipeline Review, H1 2015

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Scope

• The report provides a snapshot of the global therapeutic landscape of Esophageal Cancer

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities.

For more Information about Esophageal Cancer – Pipeline Review, H1 2015 Click:
http://www.radiantinsights.com/research/esophageal-cancer-pipeline-review-h1-2015

Mantle Cell Lymphoma – Pipeline Review, H1 2015

Global Markets Direct’s, ‘Mantle Cell Lymphoma – Pipeline Review, H1 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Scope

• The report provides a snapshot of the global therapeutic landscape of Mantle Cell Lymphoma

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

For more Information about Mantle Cell Lymphoma – Pipeline Review, H1 2015 Click:
http://www.radiantinsights.com/research/mantle-cell-lymphoma-pipeline-review-h1-2015

Diabetic Nephropathy – Pipeline Review, H1 2015

Global Markets Direct’s, ‘Diabetic Nephropathy – Pipeline Review, H1 2015’, provides an overview of the Diabetic Nephropathy’s therapeutic pipeline.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

For more Information about Diabetic Nephropathy – Pipeline Review, H1 2015 Click:
http://www.radiantinsights.com/research/diabetic-nephropathy-pipeline-review-h1-2015

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information, visit: http://www.radiantinsights.com/

Blog: http://www.terrapass.org/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/05/1430982029.png

“Radiant Insights”

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/esophageal-cancer-pipeline-review-h1-2015

Source: ABNewswire

ReleaseID: 27856